Breaking News
May 3, 2019 - Vaping and Smoking May Signal Greater Motivation to Quit
May 3, 2019 - Dementia looks different in brains of Hispanics
May 3, 2019 - Short-Staffed Nursing Homes See Drop In Medicare Ratings
May 3, 2019 - Study of teens with eating disorders explores how substance users differ from non-substance users
May 3, 2019 - Scientists develop new video game that may help in the study of Alzheimer’s
May 3, 2019 - Arc Bio introduces Galileo Pathogen Solution product line at ASM Clinical Virology Symposium
May 3, 2019 - Cornell University study uncovers relationship between starch digestion gene and gut bacteria
May 3, 2019 - How to Safely Use Glucose Meters and Test Strips for Diabetes
May 3, 2019 - Anti-inflammatory drugs ineffective for prevention of Alzheimer’s disease
May 3, 2019 - Study tracks Pennsylvania’s oil and gas waste-disposal practices
May 3, 2019 - Creating a better radiation diagnostic test for astronauts
May 3, 2019 - Vegans are often deficient in these four nutrients
May 3, 2019 - PPDC announces seed grants to develop medical devices for children
May 3, 2019 - Study maps out the frequency and impact of water polo head injuries
May 3, 2019 - Research on Reddit identifies risks associated with unproven treatments for opioid addiction
May 3, 2019 - Good smells may help ease tobacco cravings
May 3, 2019 - Medical financial hardship found to be very common among people in the United States
May 3, 2019 - Researchers develop multimodal system for personalized post-stroke rehabilitation
May 3, 2019 - Study shows significant mortality benefit with CABG over percutaneous coronary intervention
May 3, 2019 - Will gene-editing of human embryos ever be justifiable?
May 3, 2019 - FDA Approves Dengvaxia (dengue vaccine) for the Prevention of Dengue Disease in Endemic Regions
May 3, 2019 - Why Tonsillitis Keeps Coming Back
May 3, 2019 - Fighting the opioid epidemic with data
May 3, 2019 - Maggot sausages may soon be a reality
May 3, 2019 - Deletion of ATDC gene prevents development of pancreatic cancer in mice
May 2, 2019 - Targeted Therapy Promising for Rare Hematologic Cancer
May 2, 2019 - Alzheimer’s disease is a ‘double-prion disorder,’ study shows
May 2, 2019 - Reservoir bugs: How one bacterial menace makes its home in the human stomach
May 2, 2019 - Clinical, Admin Staff From Cardiology Get Sneak Peek at Epic
May 2, 2019 - Depression increases hospital use and mortality in children
May 2, 2019 - Vicon and NOC support CURE International to create first gait lab in Ethiopia
May 2, 2019 - Researchers use 3D printer to make paper organs
May 2, 2019 - Viral infection in utero associated with behavioral abnormalities in offspring
May 2, 2019 - U.S. Teen Opioid Deaths Soaring
May 2, 2019 - Opioid distribution data should be public
May 2, 2019 - In the Spotlight: “I’m learning every single day”
May 2, 2019 - 2019 Schaefer Scholars Announced
May 2, 2019 - Podcast: KHN’s ‘What The Health?’ Bye-Bye, ACA, And Hello ‘Medicare-For-All’?
May 2, 2019 - Study describes new viral molecular evasion mechanism used by cytomegalovirus
May 2, 2019 - SLU study suggests a more equitable way for Medicare reimbursement
May 2, 2019 - Scientists discover first gene involved in lower urinary tract obstruction
May 2, 2019 - Researchers identify 34 genes associated with increased risk of ovarian cancer
May 2, 2019 - Many low-income infants receive formula in the first few days of life, finds study
May 2, 2019 - Global study finds high success rate for hip and knee replacements
May 2, 2019 - Taking depression seriously: What is it?
May 2, 2019 - With Head Injuries Mounting, Will Cities Put Their Feet Down On E-Scooters?
May 2, 2019 - Scientists develop small fluorophores for tracking metabolites in living cells
May 2, 2019 - Study casts new light into how mothers’ and babies’ genes influence birth weight
May 2, 2019 - Researchers uncover new brain mechanisms regulating body weight
May 2, 2019 - Organ-on-chip systems offered to Asia-Pacific regions by Sydney’s AXT
May 2, 2019 - Adoption of new rules drops readmission penalties against safety net hospitals
May 2, 2019 - Kids and teens who consume zero-calorie sweetened beverages do not save calories
May 2, 2019 - Improved procedure for cancer-related erectile dysfunction
May 2, 2019 - Hormone may improve social behavior in autism
May 2, 2019 - Alzheimer’s disease may be caused by infectious proteins called prions
May 2, 2019 - Even Doctors Can’t Navigate Our ‘Broken Health Care System’
May 2, 2019 - Study looks at the impact on criminal persistence of head injuries
May 2, 2019 - Honey ‘as high in sugars as table sugar’
May 2, 2019 - Innovations to U.S. food system could help consumers in choosing healthy foods
May 2, 2019 - FDA Approves Mavyret (glecaprevir and pibrentasvir) as First Treatment for All Genotypes of Hepatitis C in Pediatric Patients
May 2, 2019 - Women underreport prevalence and intensity of their own snoring
May 2, 2019 - Concussion summit focuses on science behind brain injury
May 2, 2019 - Booker’s Argument For Environmental Justice Stays Within The Lines
May 2, 2019 - Cornell research explains increased metastatic cancer risk in diabetics
May 2, 2019 - Mount Sinai study provides fresh insights into cellular pathways that cause cancer
May 2, 2019 - Researchers to study link between prenatal pesticide exposures and childhood ADHD
May 2, 2019 - CoGEN Congress 2019: Speakers’ overviews
May 2, 2019 - A new strategy for managing diabetic macular edema in people with good vision
May 2, 2019 - Sagent Pharmaceuticals Issues Voluntary Nationwide Recall of Ketorolac Tromethamine Injection, USP, 60mg/2mL (30mg per mL) Due to Lack of Sterility Assurance
May 2, 2019 - Screen time associated with behavioral problems in preschoolers
May 2, 2019 - Hormone reduces social impairment in kids with autism | News Center
May 2, 2019 - Researchers synthesize peroxidase-mimicking nanozyme with low cost and superior catalytic activity
May 2, 2019 - Study results of a potential drug to treat Type 2 diabetes in children announced
May 2, 2019 - Multigene test helps doctors to make effective treatment decisions for breast cancer patients
May 2, 2019 - UNC School of Medicine initiative providing unique care to dementia patients
May 2, 2019 - Nestlé Health Science and VHP join forces to launch innovative COPES program for cancer patients
May 2, 2019 - Study examines how our brain generates consciousness and loses it during anesthesia
May 2, 2019 - Transition Support Program May Aid Young Adults With Type 1 Diabetes
May 2, 2019 - Study shows how neutrophils exacerbate atherosclerosis by inducing smooth muscle-cell death
May 2, 2019 - Research reveals complexity of how we make decisions
New biomarker may help better predict outcomes in patients with HPV-related head and neck cancers

New biomarker may help better predict outcomes in patients with HPV-related head and neck cancers

Gene signature may allow clinicians to better stratify patients and reduce treatment intensity to lower side effects

By analyzing variations in the level of human papillomavirus (HPV) in head and neck cancers, researchers at The University of Texas MD Anderson Cancer Center have discovered a gene signature associated with treatment response and survival in patients. Rather than simply classifying tumors as HPV-positive or HPV-negative, this biomarker may one day enable clinicians to better predict patient outcomes, ultimately allowing for reduced treatment intensity to minimize severe side effects.

The study, published today in JCI Insight, identified a subset of patients with HPV-positive head and neck, or oropharyngeal, cancers with a molecular profile and survival rates similar to HPV-negative cancers, which typically have poor outcomes. The researchers discovered a gene panel that distinguished this subgroup and appeared predictive of outcome in multiple independent cohorts.

According to the Centers for Disease Control and Prevention (CDC), more than 18,000 cases of oropharyngeal cancer are diagnosed each year in the U.S., with HPV infection responsible for roughly 70 percent of all cases.

Standard care for HPV-positive oropharyngeal cancers is a combination of chemotherapy and radiation with a five-year survival rate of approximately 85 percent, compared to just 55 percent for HPV-negative cancers, explained Curtis Pickering, Ph.D., assistant professor of Head and Neck Surgery and corresponding author on the study.

“Patients with HPV-positive oropharyngeal tumors are living a long time after radiation treatment, but often are left with significant long-term morbidity, including problems with speech or swallowing,” said Pickering. “Therefore, there’s a desire among clinicians to reduce, or de-escalate, therapy to lessen severe side effects. However, we currently don’t have good biomarkers to safely determine which patients are candidates for de-escalation.”

To better understand the role of HPV biology in patient outcome and identify biomarkers associated with treatment response, the research team analyzed data from 80 oropharyngeal cancers included in The Cancer Genome Atlas (TCGA). Rather than simply classifying tumors as HPV-positive or HPV-negative, the researchers examined all tumors based on their level of HPV gene expression.

“That led us to an expression signature that neatly identified two different groups within the HPV-positive patients,” said Pickering. “The HPV-negative tumors were clearly different, but within HPV-positive there were two different groups. That was biologically interesting, but one HPV-positive subgroup had survival similar to those of HPV-negative patients.”

The researchers found an initial panel of 582 genes that distinguished these three subgroups — a high HPV group, a low HPV group and an HPV-negative group — each with statistically significant survival differences. Further analyses led to a panel of just 38 genes that are able to distinguish between the two HPV-positive subgroups.

A variety of genetic analyses confirmed the distinction between these groups, and the researchers discovered two viral genes not generally thought to be important for tumor progression that were significantly different between the HPV-positive groups. Further, cell line studies showed these genes to be correlated with radiation sensitivity, in alignment with responses seen in patients.

Recognizing the potential value of this gene signature for predicting treatment response, the researchers evaluated the biomarker in two independent patient cohorts of HPV-related oropharyngeal and cervical cancers. In each case, the gene panel appeared to be prognostic of survival and performed better than available clinical factors, such as smoking status and tumor size. After further refining their gene panel, the researchers believe that the biomarker could be reduced to as small as a single gene with similar prognostic ability.

“What I’m hoping is we’ve found some new fundamental aspects of HPV biology related to the carcinogenic process, the progression of the tumor and response to therapy,” said Pickering. “If we’re able to validate this in future studies, it could be incredibly clinically useful across several HPV-related tumor types.”

The current retrospective study was limited by relatively small cohort sizes and reliance on RNA sequencing data; therefore the research team hopes to evaluate their biomarker in prospective trials after developing an assay sufficient for clinical use.

Source:

https://www.mdanderson.org/newsroom/novel-biomarker-appears-predictive-of-outcome-in-patients-with-hpv-related-head-and-neck-cancers.h00-159299889.html

Tagged with:

About author

Related Articles